USD 482.58
↑ 12.71 (2.71%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| ANTM | 0 | 0 | 0 | 0 | 0 | 8.7 | 63.0 | 107.3 | 631.1 | 2259.8 |
| S&P 500 | -0.2 | -0.1 | 1.9 | 9.5 | 13.8 | 32.8 | 27.5 | 92.8 | 192.8 | 33714.3 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | ANTM |
| name | Elevance Health Inc. |
| price | 482.58 |
| changes percentage | 2.705 |
| change | 12.71 |
| day low | 466.74 |
| day high | 485.745 |
| year high | 533.68 |
| year low | 355.4333 |
| market cap | 114592481640 |
| price avg 50 | 489.2554 |
| price avg 200 | 456.09894 |
| exchange | NYSE |
| volume | 1274535 |
| avg volume | 1177335 |
| open | 469.53 |
| previous close | 469.87 |
| eps | 25.41 |
| pe | 18.991736 |
| earnings announcement | None |
| shares outstanding | 237458000 |
| timestamp | 2022-06-28 04:00:00 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001156039 | |||
| revenue | 171340000000 | 156595000000 | 9.42 |
| gross profit | 47010000000 | 39953000000 | 17.66 |
| gross profit ratio | 0.27 | 0 | NaN |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 38265000000 | 31502000000 | 21.47 |
| interest income | 0 | 0 | NaN |
| interest expense | 1030000000 | 851000000 | 21.03 |
| ebitda | 10490000000 | 10126000000 | 3.59 |
| ebitdaratio | 0.06 | 0.06 | 1.52 |
| operating income | 133960000000 | 8451000000 | 1485.14 |
| operating income ratio | 0.78 | 0.05 | 1348.73 |
| net income | 5987000000 | 5894000000 | 1.58 |
| net income ratio | 0.03 | 0.04 | -7.16 |
| eps | 25.38 | 24.56 | 3.35 |
Revenue Growth: revenue increased to 171,340 million in 2023 from 156,595 million in 2022 representing a change of 9.42%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 47,010 million in 2023 from 39,953 million in 2022 representing a change of 17.66%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 10,490 million in 2023 from 10,126 million in 2022 representing a change of 3.59%. The increase in EBITDA indicates improved operational efficiency and profitability.
Net Income: Net income increased to 5,987 million in 2023 from 5,894 million in 2022 representing a change of 1.58%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 25.38 in 2023 from 25.38 in 2022 representing a change of 3.35%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 38,265 million in 2023 from 31,502 million in 2022 representing a change of 21.47%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Operating Income: Operating income decreased to 133,960 million in 2023 from 8,451 million in 2022 representing a change of 1485.14%. The decrease in operating income indicates worse operational performance and decreased profitability.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001156039 | |||
| revenue | 45145000000 | 43646000000 | 3.43 |
| gross profit | 12196000000 | 13074000000 | -6.72 |
| gross profit ratio | 0.27 | 0 | NaN |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 10484000000 | 10048000000 | 4.34 |
| interest income | 0 | 0 | NaN |
| interest expense | 300000000 | 280000000 | 7.14 |
| ebitda | 2002000000 | 3601000000 | -44.40 |
| ebitdaratio | 0.04 | -0.0 | 4820.79 |
| operating income | 1712000000 | 3026000000 | -43.42 |
| operating income ratio | 0.04 | 0.07 | -45.30 |
| net income | 1016000000 | 2300000000 | -55.83 |
| net income ratio | 0.02 | 0.05 | -57.29 |
| eps | 4.36 | 9.91 | -55.98 |
Revenue Growth: revenue increased to 45,145 million in 2024Q3 from 43,646 million in 2024Q2 representing a change of 3.43%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit decreased to 12,196 million in 2024Q3 from 13,074 million in 2024Q2 representing a change of -6.72%. This indicates a sales profitability decline, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 10,484 million in 2024Q3 from 10,048 million in 2024Q2 representing a change of 4.34%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 2,002 million in 2024Q3 from 3,601 million in 2024Q2 representing a change of -44.4%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 1,712 million in 2024Q3 from 3,026 million in 2024Q2 representing a change of -43.42%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 1,016 million in 2024Q3 from 2,300 million in 2024Q2 representing a change of -55.83%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 4.36 in 2024Q3 from 4.36 in 2024Q2 representing a change of -55.98%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001156039 | |||
| total assets | 108928000000 | 102772000000 | 5.99 |
| total liabilities | 69523000000 | 66378000000 | 4.74 |
| total equity | 39405000000 | 36394000000 | 8.27 |
| cash and cash equivalents | 6526000000 | 7387000000 | -11.66 |
| short term investments | 29614000000 | 25952000000 | 14.11 |
| long term investments | 30719000000 | 27657000000 | 11.07 |
| total current assets | 60029000000 | 55617000000 | 7.93 |
| total non current assets | 48899000000 | 47155000000 | 3.70 |
| total current liabilities | 41791000000 | 39696000000 | 5.28 |
| total non current liabilities | 27732000000 | 26682000000 | 3.94 |
| common stock | 2000000 | 2000000 | 0.00 |
| retained earnings | 31749000000 | 29724000000 | 6.81 |
| total debt | 25120000000 | 24114000000 | 4.17 |
Total Assets: Total Assets increased to 108,928 million in 2023 from 102,772 million in 2022 representing a change of 5.99%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 39,405 million in 2023 from 36,394 million in 2022 representing a change of 8.27%. This indicates an increase in shareholders' equity.
Short Term Investments: Short Term Investments increased to 29,614 million in 2023 from 25,952 million in 2022 representing a change of 14.11%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 60,029 million in 2023 from 55,617 million in 2022 representing a change of 7.93%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 31,749 million in 2023 from 29,724 million in 2022 representing a change of 6.81%. This indicates an accumulated profits.
Total Liabilities: Total Liabilities increased to 69,523 million in 2023 from 66,378 million in 2022 representing a change of 4.74%. This indicates an increase in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 6,526 million in 2023 from 7,387 million in 2022 representing a change of -11.66%. This indicates a decrease in available liquid assets.
Total Current Liabilities: Total Current Liabilities increased to 41,791 million in 2023 from 39,696 million in 2022 representing a change of 5.28%. This indicates a higher short-term debt burden.
Total Debt: Total Debt increased to 25,120 million in 2023 from 24,114 million in 2022 representing a change of 4.17%. This indicates an increase in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001156039 | |||
| total assets | 116533000000 | 112988000000 | 3.14 |
| total liabilities | 72654000000 | 70691000000 | 2.78 |
| total equity | 43879000000 | 42297000000 | 3.74 |
| cash and cash equivalents | 7866000000 | 6497000000 | 21.07 |
| short term investments | 28954000000 | 29494000000 | -1.83 |
| long term investments | 30960000000 | 30343000000 | 2.03 |
| total current assets | 62846000000 | 62274000000 | 0.92 |
| total non current assets | 53687000000 | 50714000000 | 5.86 |
| total current liabilities | 42033000000 | 41813000000 | 0.53 |
| total non current liabilities | 30621000000 | 28878000000 | 6.04 |
| common stock | 2000000 | 2000000 | 0.00 |
| retained earnings | 35157000000 | 34575000000 | 1.68 |
| total debt | 27148000000 | 27686000000 | -1.94 |
Total Assets: Total Assets increased to 116,533 million in 2024Q3 from 112,988 million in 2024Q2 representing a change of 3.14%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 43,879 million in 2024Q3 from 42,297 million in 2024Q2 representing a change of 3.74%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 7,866 million in 2024Q3 from 6,497 million in 2024Q2 representing a change of 21.07%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 62,846 million in 2024Q3 from 62,274 million in 2024Q2 representing a change of 0.92%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 35,157 million in 2024Q3 from 34,575 million in 2024Q2 representing a change of 1.68%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 27,148 million in 2024Q3 from 27,686 million in 2024Q2 representing a change of -1.94%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 72,654 million in 2024Q3 from 70,691 million in 2024Q2 representing a change of 2.78%. This indicates an increase in overall liabilities.
Short Term Investments: Short Term Investments decreased to 28,954 million in 2024Q3 from 29,494 million in 2024Q2 representing a change of -1.83%. This indicates a decrease in short-term investment holdings.
Total Current Liabilities: Total Current Liabilities increased to 42,033 million in 2024Q3 from 41,813 million in 2024Q2 representing a change of 0.53%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001156039 | |||
| net change in cash | -861000000 | 2507000000 | -134.34 |
| operating cash flow | 8061000000 | 8399000000 | -4.02 |
| free cash flow | 6765000000 | 7247000000 | -6.65 |
| capital expenditure | -1296000000 | -1152000000 | -12.50 |
| depreciation and amortization | 1745000000 | 1675000000 | 4.18 |
| deferred income tax | -602000000 | -76000000 | -692.11 |
| stock based compensation | 289000000 | 264000000 | 9.47 |
| accounts payables | 1640000000 | 252000000 | 550.79 |
| inventory | 0 | 2510000000 | -100.00 |
| acquisitions net | -1552000000 | -649000000 | -139.14 |
| investments in property plant and equipment | -1296000000 | -1152000000 | -12.50 |
| net cash used for investing activites | -5572000000 | -4560000000 | -22.19 |
| debt repayment | 665000000 | 1172000000 | -43.26 |
| common stock issued | 152000000 | 0 | NaN |
| common stock repurchased | -2676000000 | -2316000000 | -15.54 |
| dividends paid | -1395000000 | -1229000000 | -13.51 |
| net cash used provided by financing activities | -3349000000 | -1318000000 | -154.10 |
| cash at end of period | 6526000000 | 7387000000 | -11.66 |
| accounts receivables | 0 | -2510000000 | 100.00 |
| cash at beginning of period | 7387000000 | 4880000000 | 51.37 |
Net Change in Cash: Net Change in Cash decreased to -861 million in 2023 from 2,507 million in 2022 representing a change of -134.34%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow decreased to 8,061 million in 2023 from 8,399 million in 2022 representing a change of -4.02%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 6,765 million in 2023 from 7,247 million in 2022 representing a change of -6.65%. This indicates a decrease in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation increased to 289 million in 2023 from 264 million in 2022 representing a change of 9.47%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 1,640 million in 2023 from 252 million in 2022 representing a change of 550.79%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 0 in 2023 from -2,510 million in 2022 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.
Dividends Paid: Dividends Paid decreased to -1,395 million in 2023 from -1,229 million in 2022 representing a change of -13.51%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
Capital Expenditure: Capital Expenditure decreased to -1,296 million in 2023 from -1,152 million in 2022 representing a change of -12.5%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001156039 | |||
| operating cash flow | 2677000000 | 447000000 | 498.88 |
| free cash flow | 2345000000 | 124000000 | 1791.13 |
| capital expenditure | -332000000 | -323000000 | -2.79 |
| depreciation and amortization | 329000000 | 335000000 | -1.79 |
| deferred income tax | -224000000 | -170000000 | -31.76 |
| stock based compensation | 66000000 | 92000000 | -28.26 |
| accounts receivables | 851000000 | -1059000000 | 180.36 |
| accounts payables | 628000000 | 557000000 | 12.75 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 395000000 | -100.00 |
| investments in property plant and equipment | -332000000 | -323000000 | -2.79 |
| net cash used for investing activites | -401000000 | -818000000 | 50.98 |
| debt repayment | -358000000 | 1337000000 | -126.78 |
| common stock issued | 48000000 | 0 | NaN |
| common stock repurchased | -60000000 | -463000000 | 87.04 |
| dividends paid | -378000000 | -378000000 | 0.00 |
| net cash used provided by financing activities | -915000000 | 668000000 | -236.98 |
| net change in cash | 1369000000 | 271000000 | 405.17 |
| cash at end of period | 7866000000 | 6497000000 | 21.07 |
| cash at beginning of period | 6497000000 | 6226000000 | 4.35 |
Net Change in Cash: Net Change in Cash increased to 1,369 million in 2024Q3 from 271 million in 2024Q2 representing a change of 405.17%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 2,677 million in 2024Q3 from 447 million in 2024Q2 representing a change of 498.88%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 2,345 million in 2024Q3 from 124 million in 2024Q2 representing a change of 1791.13%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -332 million in 2024Q3 from -323 million in 2024Q2 representing a change of -2.79%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 66 million in 2024Q3 from 92 million in 2024Q2 representing a change of -28.26%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 628 million in 2024Q3 from 557 million in 2024Q2 representing a change of 12.75%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 851 in 2024Q3 from -1,059 million in 2024Q2 representing a change of 180.36%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 726.32 | 652.48 | 11.32 |
| net income per share | 25.38 | 24.56 | 3.34 |
| operating cash flow per share | 34.17 | 35.0 | -2.36 |
| free cash flow per share | 28.68 | 30.2 | -5.03 |
| cash per share | 153.2 | 138.91 | 10.29 |
| book value per share | 167.04 | 151.64 | 10.16 |
| tangible book value per share | 16.17 | 7.07 | 128.85 |
| shareholders equity per share | 166.62 | 151.28 | 10.14 |
| interest debt per share | 110.85 | 104.02 | 6.57 |
| market cap | 111241004000 | 123112800000 | -9.64 |
| enterprise value | 129835004000 | 139839800000 | -7.15 |
| pe ratio | 18.58 | 20.89 | -11.05 |
| price to sales ratio | 0.65 | 0.79 | -17.42 |
| pocfratio | 13.8 | 14.66 | -5.85 |
| pfcf ratio | 16.44 | 16.99 | -3.21 |
| pb ratio | 2.83 | 3.39 | -16.54 |
| ptb ratio | 2.83 | 3.39 | -16.54 |
| ev to sales | 0.76 | 0.89 | -15.14 |
| enterprise value over ebitda | 12.38 | 13.81 | -10.38 |
| ev to operating cash flow | 16.11 | 16.65 | -3.26 |
| ev to free cash flow | 19.19 | 19.3 | -0.54 |
| earnings yield | 0.05 | 0.05 | 12.42 |
| free cash flow yield | 0.06 | 0.06 | 3.31 |
| debt to equity | 0.64 | 0.66 | -3.78 |
| debt to assets | 0.23 | 0.23 | -1.72 |
| net debt to ebitda | 1.77 | 1.65 | 7.30 |
| current ratio | 1.44 | 1.4 | 2.52 |
| interest coverage | 130.06 | 9.93 | 1209.66 |
| income quality | 1.35 | 1.4 | -3.58 |
| dividend yield | 0.01 | 0.01 | 25.62 |
| payout ratio | 0.23 | 0.21 | 11.74 |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.33 | 0.34 | -3.23 |
| capex to operating cash flow | 0.16 | 0.14 | 17.22 |
| capex to revenue | 0.01 | 0.01 | 2.82 |
| capex to depreciation | 0.74 | 0.69 | 7.99 |
| stock based compensation to revenue | 0.0 | 0.0 | 0.05 |
| graham number | 308.46 | 289.12 | 6.69 |
| roic | 1.61 | 0.11 | 1390.06 |
| return on tangible assets | 0.08 | 0.09 | -5.71 |
| graham net net | -109.84 | -133.37 | 17.64 |
| working capital | 18238000000 | 15921000000 | 14.55 |
| tangible asset value | 3815000000 | 1696000000 | 124.94 |
| net current asset value | -9494000000 | -10761000000 | 11.77 |
| invested capital | 58187000000 | 54935000000 | 5.92 |
| average receivables | 9462000000 | 8360000000 | 13.18 |
| average payables | 14314000000 | 12047500000 | 18.81 |
| average inventory | -5690500000 | -24932000000 | 77.18 |
| days sales outstanding | 21.22 | 20.89 | 1.61 |
| days payables outstanding | 67.58 | 17.55 | 285.19 |
| days of inventory on hand | 0 | -35.61 | 100.00 |
| receivables turnover | 17.2 | 17.48 | -1.59 |
| payables turnover | 5.4 | 20.8 | -74.04 |
| inventory turnover | 0 | -10.25 | 100.00 |
| roe | 0.15 | 0.16 | -6.17 |
| capex per share | 5.49 | 4.8 | 14.46 |
ROE: Return on Equity (ROE) decreased to 0.15 on 2023-12-31 from 0.16 on 2022-12-31, representing a change of -6.17%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 18.58 on 2023-12-31 from 20.89 on 2022-12-31, representing a change of -11.05%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.44 on 2023-12-31 from 1.40 on 2022-12-31, representing a change of 2.52%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.64 on 2023-12-31 from 0.66 on 2022-12-31, representing a change of -3.78%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| ANTM | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 193.73 | 187.97 | 3.07 |
| net income per share | 4.36 | 9.91 | -55.98 |
| operating cash flow per share | 11.49 | 1.93 | 496.75 |
| free cash flow per share | 10.06 | 0.53 | 1784.41 |
| cash per share | 158.01 | 155 | 1.94 |
| book value per share | 188.3 | 182.16 | 3.37 |
| tangible book value per share | 32.56 | 25.36 | 28.40 |
| shareholders equity per share | 187.85 | 181.7 | 3.39 |
| interest debt per share | 117.79 | 120.44 | -2.20 |
| market cap | 121174311440 | 124122510000.0 | -2.38 |
| enterprise value | 140456311440 | 145311510000 | -3.34 |
| pe ratio | 29.82 | 13.49 | 121.00 |
| price to sales ratio | 2.68 | 2.84 | -5.62 |
| pocfratio | 45.26 | 277.68 | -83.70 |
| pfcf ratio | 51.67 | 1000.99 | -94.84 |
| pb ratio | 2.77 | 2.94 | -5.91 |
| ptb ratio | 2.77 | 2.94 | -5.91 |
| ev to sales | 3.11 | 3.33 | -6.55 |
| enterprise value over ebitda | 70.16 | 40.35 | 73.86 |
| ev to operating cash flow | 52.47 | 325.08 | -83.86 |
| ev to free cash flow | 59.9 | 1171.87 | -94.89 |
| earnings yield | 0.01 | 0.02 | -54.75 |
| free cash flow yield | 0.02 | 0.0 | 1837.14 |
| debt to equity | 0.62 | 0.66 | -5.49 |
| debt to assets | 0.23 | 0.25 | -4.93 |
| net debt to ebitda | 9.63 | 5.88 | 63.68 |
| current ratio | 1.5 | 1.49 | 0.39 |
| interest coverage | 5.71 | 10.81 | -47.20 |
| income quality | 2.66 | 0.19 | 1266.50 |
| dividend yield | 0.0 | 0.0 | 2.43 |
| payout ratio | 0.37 | 0.16 | 126.38 |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.31 | 0.32 | -3.35 |
| capex to operating cash flow | 0.12 | 0.72 | -82.84 |
| capex to revenue | 0.01 | 0.01 | -0.63 |
| capex to depreciation | 1.01 | 0.96 | 4.66 |
| stock based compensation to revenue | 0.0 | 0.0 | -30.64 |
| graham number | 135.75 | 201.23 | -32.54 |
| roic | 0.02 | 0.03 | -46.89 |
| return on tangible assets | 0.01 | 0.03 | -57.84 |
| graham net net | -117.76 | -151.4 | 22.22 |
| working capital | 20813000000 | 20461000000 | 1.72 |
| tangible asset value | 7587000000 | 5888000000 | 28.86 |
| net current asset value | -9808000000 | -8417000000 | -16.53 |
| invested capital | 61610000000 | 61320000000 | 0.47 |
| average receivables | 11184000000 | 5589000000 | 100.11 |
| average payables | 6007500000 | 5728000000 | 4.88 |
| average inventory | -8837500000 | -35862000000 | 75.36 |
| days sales outstanding | 22.31 | 23.05 | -3.22 |
| days payables outstanding | 17.09 | 16.96 | 0.76 |
| days of inventory on hand | 0 | -52.03 | 100.00 |
| receivables turnover | 4.03 | 3.9 | 3.32 |
| payables turnover | 5.27 | 5.31 | -0.75 |
| inventory turnover | 0 | -1.73 | 100.00 |
| roe | 0.02 | 0.05 | -57.42 |
| capex per share | 1.42 | 1.39 | 2.42 |
ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.05 on 2024-06-30 Q2, representing a change of -57.42%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 29.82 on 2024-09-30 Q3 from 13.49 on 2024-06-30 Q2, representing a change of 121.00%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.50 on 2024-09-30 Q3 from 1.49 on 2024-06-30 Q2, representing a change of 0.39%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.62 on 2024-09-30 Q3 from 0.66 on 2024-06-30 Q2, representing a change of -5.49%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Negative
Publish Date: 2024-10-24 10:16:00
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5% senior unsecured bonds, due 2026; $750 million, 4.750% senior unsecured bonds, due 2030; $750 million, 4.95% senior unsecured bonds, due 2031; $1.2 billion, 5.2% senior unsecured bonds, due 2035; $1.35 billion, 5.7% senior unsecured bonds, due 2055; and $800 million, 5.85% senior unsecured bonds, due.
Sentiment: Positive
Publish Date: 2024-10-17 11:23:00
RICHMOND, Va.--(BUSINESS WIRE)--The Anthem Blue Cross and Blue Shield Foundation (Anthem) has provided a $50,000 grant to the McShin Foundation to help increase access to stable housing and peer recovery support services for individuals with substance use disorders (SUDs). “Substance use disorder is a major public health challenge that affects not only the health of individuals, but entire communities,” said Alyssa Ward, Ph.D., LCP, Behavioral Health Director, Anthem Blue Cross and Blue Shield.
Sentiment: Positive
Publish Date: 2024-10-16 22:03:00
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ The final long form prospectus is accessible through SEDAR+ VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Anthem Citizen Real Estate Development Trust (the “REDT”) announced today that it has received expressions of interest and commitments that in the aggregate are expected to achieve the maximum offering amount of C$82 million and has filed with the securities regulatory authorities in each of the provinces and territories of Canada, and obtained a receipt for, a final prospectus (the “Prospectus”) for an initial public offering of its trust units (the “Offering”). It is expected that the Offering will close on October 29, 2024.
Sentiment: Positive
Publish Date: 2024-10-15 18:12:00
WOODSTOCK, Va.--(BUSINESS WIRE)--As part of its parent company's three-year, $30 million commitment to programs supporting mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation unveiled an initiative in Shenandoah County, Virginia, to address the substance use disorder crisis among children and adolescents. Through a $750,000 grant awarded to its long-standing non-profit partner, The Open Table, Inc., Anthem has funded an initiative focused on “Strengthening Shenandoah”.
Sentiment: Positive
Publish Date: 2024-10-15 17:48:00
CALGARY, Alberta, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Anthem Properties Group, development manager of the master planned community of Cornerstone in NE Calgary, today celebrated the opening of the first phase of a multi-phase, multi-amenity regional park system that is being constructed in collaboration with The City of Calgary. The regional park system, which is being built for the benefit of all residents in the region, completed its first round of online and in-person engagement in Winter 2023 and has four areas of public use surrounding a central 120-acre Environmental Reserve area protecting an existing natural wetland complex.
Sentiment: Positive
Publish Date: 2024-10-08 08:30:00
BOCA RATON, Fla.--(BUSINESS WIRE)--Dover Fueling Solutions® (DFS), a part of Dover Corporation and a leading global provider of advanced customer-focused technologies, services and solutions in the fuel and convenience retail industries, and GRUBBRR®, a global leader in self-ordering solutions, are excited to announce that they are giving any fueling site equipped with the DFS Anthem UX® platform a full year of DX Market™ powered by GRUBBRR® subscription free. DX Market™ powered by GRUBBRR® is.
Sentiment: Positive
Publish Date: 2024-09-30 10:45:00
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health and its philanthropic arm, Elevance Health Foundation, are committed to strengthening the health of communities across the U.S. through community resiliency and disaster response efforts related to Hurricane Helene. Elevance Health and its Foundation are providing $500,000 in new grant funding to help communities affected by Hurricane Helene. As needs continue to arise, this funding will ensure community-based organizations are equipped to mobilize.
Sentiment: Positive
Publish Date: 2024-09-11 17:16:00
RICHMOND, Va.--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield Foundation in Virginia, a philanthropic arm of Elevance Health Foundation, announced today an additional $100,000 each to three foods banks granted across the Commonwealth to further expand the ‘Food as Medicine' program. This initiative will support the Blue Ridge Area Food Bank, Feeding Southwest Virginia, and the Foodbank of Southeastern Virginia and the Eastern Shore as they collaborate with local health care partners to scre.
Sentiment: Positive
Publish Date: 2024-09-10 20:30:00
VANCOUVER, British Columbia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Anthem Properties Group has launched an initial public offering on its 66 storey, mixed-use development, Citizen, located in the heart of Metrotown in Burnaby, British Columbia, with the goal of increasing housing availability in a critically constrained market. Units in this IPO will be issued through the newly created Anthem Citizen Real Estate Development Trust.
Sentiment: Positive
Publish Date: 2024-09-10 20:07:00
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Anthem Citizen Real Estate Development Trust (the “REDT”) announced today that it has filed, and obtained a receipt for, a preliminary prospectus with the securities regulatory authorities in each of the provinces and territories of Canada for a proposed initial public offering of its trust units (the “Offering”).
Sentiment: Positive
Publish Date: 2024-08-22 14:43:38
Country band The Chicks will perform the U.S. national anthem at the Democratic National Convention where Vice President Kamala Harris will formally accept the party's 2024 presidential nomination on Thursday night, a source said.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
